Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Completed 116Terminated 18Active not recruiting 9Recruiting 6Withdrawn 5Unknown 3Not yet recruiting 2

Sponsor Class

OTHER 44INDUSTRY 11NETWORK 2OTHER_GOV 1NIH 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Lymphoid 2Other hematologic neoplasm 1

Conditions

Melanoma 3Leukemia, Myeloid, Acute 3Carcinoma, Non-Small-Cell Lung 3Sarcoma, Kaposi 2Sarcoma, Alveolar Soft Part 2Prostatic Neoplasms 2Non-Muscle Invasive Bladder Neoplasms 2Lymphoma 2Colorectal Neoplasms 2Carcinoma, Renal Cell 2Breast Neoplasms 2Urinary Incontinence 1Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Solid Tumor 1Skin Neoplasms 1Sarcoma, Synovial 1Sarcoma, Clear Cell 1Sarcoma 1Rhabdomyosarcoma 1Recurrence 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Neoplasms 1Neurofibrosarcoma 1Neoplasms 1Musculoskeletal Pain 1Multiple Myeloma 1Malignant Solid Neoplasm 1Lymphoma, Non-Hodgkin 1

Interventions

prednylidene 1pegaspargase 1nelarabine 1merphos 1exifone 1dexamethasone acetate 1dexamethasone 21-phosphate 1deltacortene 1daratumumab 1calaspargase pegol 1auricularum 1Vincristine 1Thioguanine 1Spinal Puncture 1Specimen Handling 1Radiotherapy 1Radiation 1Prednisone 1Prednisolone 1Methylprednisolone 1Methotrexate 1Mercaptopurine 1Medrol Veriderm 1Magnetic Resonance Spectroscopy 1Hydrocortisone 1High-Energy Shock Waves 1Doxorubicin 1Dexamethasone 1Daunorubicin 1Cytarabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Not yet recruiting × NETWORK × Lymphoma × Clear all
NCT07072585 2025-12-31

Testing the Addition of Daratumumab to Chemotherapy for Treating Patients With Newly-Diagnosed T-Cell Lymphoblastic Leukemia (T-ALL) and T-Cell Lymphoblastic Lymphoma (T-LL)

Children's Oncology Group

Phase 2/3 Not yet recruiting
1,708 enrolled
LymphoidOther hematologic neoplasm

Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT06757478 2025-03-18

A Clinical Study on the Combination of Mitoxantrone Liposome Injection, Bendamustine, Etoposide, and Cytarabine for Pretreatment of Autologous Hematopoietic Stem Cell Transplantation in Patients with Lymphoma

First Affiliated Hospital of Ningbo University

Not yet recruiting
30 enrolled
Lymphoid

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡